ENPP1 Program(Rallybio)

N/A

Report date: 2024/12/12 11:06:41
NME

Base Information

Drug NameENPP1 Program(Rallybio)
Drug Alias NameREV-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitors
TargetsEctonucleotide Pyrophosphatase/Phosphodiesterase 1
Therapy Area/IndicationsHypophosphatasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRallybio CorpRecursion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRecursion Pharmaceuticals IncRallybio Corp
Inactive CompaniesN/A
Active IndicationsHypophosphatasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A